LAVAL, Quebec, July 9, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti”) (TSX-V:APO), a Neptune Technologies & Bioressources Inc. (“Neptune”) subsidiary, announces it will present at the 2012 JMP Securities Healthcare Conference:
LAVAL, Quebec, July 9, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti”) (TSX-V:APO), a Neptune Technologies & Bioressources Inc. (“Neptune”) subsidiary, announces it will present at the 2012 JMP Securities Healthcare Conference:
